<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>BROMOCRIPTINE - Research Report</title>
    <meta name="description" content="Comprehensive naturopathic research report for BROMOCRIPTINE">
    <style>

    * {
        box-sizing: border-box;
    }

    body {
        font-family: 'Segoe UI', 'Helvetica Neue', Arial, sans-serif;
        font-size: 16px;
        line-height: 1.6;
        margin: 0;
        padding: 0;
        background-color: #f8f9fa;
        color: #212529;
    }

    .container {
        max-width: 1200px;
        margin: 0 auto;
        padding: 20px;
        background-color: white;
        box-shadow: 0 0 10px rgba(0,0,0,0.1);
    }

    .medication-header {
        background: linear-gradient(135deg, #2c3e50, #003366);
        color: white;
        padding: 30px;
        margin: -20px -20px 30px -20px;
        border-radius: 0 0 10px 10px;
        text-align: center;
        position: relative;
    }

    .medication-header h1 {
        margin: 0 0 15px 0;
        font-size: 2.5em;
        font-weight: 600;
        text-shadow: 0 2px 4px rgba(0,0,0,0.3);
    }

    .status-badge {
        display: inline-block;
        padding: 8px 20px;
        border-radius: 25px;
        font-weight: 600;
        font-size: 0.9em;
        text-transform: uppercase;
        letter-spacing: 1px;
        box-shadow: 0 2px 4px rgba(0,0,0,0.2);
    }

    .status-allowed { background-color: #28a745; color: white; }
    .status-not-allowed { background-color: #dc3545; color: white; }
    .status-modernization { background-color: #fd7e14; color: white; }
    .status-topical { background-color: #20c997; color: white; }
    .status-review { background-color: #ffc107; color: #212529; }
    .status-not-applicable { background-color: #6c757d; color: white; }
    .status-unknown { background-color: #adb5bd; color: white; }

    .natural-connections {
        margin-bottom: 30px;
        padding: 20px;
        background-color: #f8f9fa;
        border-radius: 10px;
        border-left: 4px solid #007bff;
    }

    .natural-connections h2 {
        margin: 0 0 15px 0;
        font-size: 1.4em;
        color: #2c3e50;
    }

    .connection-tags {
        display: flex;
        flex-wrap: wrap;
        gap: 8px;
    }

    .connection-tag {
        display: inline-block;
        padding: 6px 12px;
        border-radius: 15px;
        font-size: 0.85em;
        font-weight: 500;
        color: white;
        white-space: nowrap;
    }

    .tag-direct { background-color: #0d6832; }
    .tag-semi-synthetic { background-color: #198754; }
    .tag-structural { background-color: #0d6efd; }
    .tag-endogenous { background-color: #6610f2; }
    .tag-biosynthetic { background-color: #6f42c1; }
    .tag-pathways { background-color: #0dcaf0; color: #212529; }
    .tag-processes { background-color: #3dd5f3; color: #212529; }

    .report-content {
        line-height: 1.7;
    }

    .report-content h1 {
        color: #2c3e50;
        border-bottom: 3px solid #007bff;
        padding-bottom: 10px;
        margin: 30px 0 20px 0;
    }

    .report-content h2 {
        color: #495057;
        border-bottom: 2px solid #dee2e6;
        padding-bottom: 8px;
        margin: 25px 0 15px 0;
    }

    .report-content h3 {
        color: #6c757d;
        margin: 20px 0 10px 0;
    }

    .report-content p {
        margin-bottom: 15px;
        text-align: justify;
    }

    .checkbox {
        font-weight: bold;
        margin-right: 5px;
    }

    .checkbox.checked { color: #28a745; }
    .checkbox.unchecked { color: #6c757d; }

    .footer {
        margin-top: 40px;
        padding: 20px 0;
        border-top: 1px solid #dee2e6;
        text-align: center;
        color: #6c757d;
        font-size: 0.9em;
    }

    .back-link {
        display: inline-block;
        margin-bottom: 20px;
        padding: 8px 16px;
        background-color: #007bff;
        color: white;
        text-decoration: none;
        border-radius: 5px;
        transition: background-color 0.3s;
    }

    .back-link:hover {
        background-color: #0056b3;
        text-decoration: none;
    }

    @media (max-width: 768px) {
        .container {
            padding: 15px;
            margin: 10px;
        }
        .medication-header {
            margin: -15px -15px 20px -15px;
            padding: 20px;
        }
        .medication-header h1 {
            font-size: 2em;
        }
        .connection-tags {
            justify-content: center;
        }
    }

    @media print {
        .back-link { display: none; }
        .container { box-shadow: none; }
        .medication-header {
            background: #2c3e50 !important;
            -webkit-print-color-adjust: exact;
        }
    }

    </style>
</head>
<body>
    <div class="container">
        <a href="index.html" class="back-link">← Back to Index</a>

        <header class="medication-header">
            <h1>BROMOCRIPTINE</h1>
            <div class="status-badge status-modernization">
                TARGET_FOR_MODERNIZATION
            </div>
        </header>

        <section class="natural-connections">
            <h2>Natural Connections</h2>
            <div class="connection-tags">
                <span class="connection-tag tag-semi-synthetic">Semi-Synthetic</span>
<span class="connection-tag tag-structural">Structural Analog</span>
<span class="connection-tag tag-endogenous">Endogenous Compound</span>
<span class="connection-tag tag-pathways">Works Natural Pathways</span>
<span class="connection-tag tag-processes">Facilitates Natural Processes</span>
            </div>
        </section>

        <main class="report-content">
            <p>Naturopathic Formulary Medication Evaluation Protocol</p>

<p># Objective: Comprehensive assessment of natural derivation and therapeutic alignment For <strong>BROMOCRIPTINE</strong>:</p>

<strong>Evidence Categories Present:</strong>

<span class="checkbox unchecked">☐</span> Direct natural source <span class="checkbox checked">✓</span> Semi-synthetic from natural precursor <span class="checkbox checked">✓</span> Structural analog of natural compound <span class="checkbox checked">✓</span> Endogenous compound or replacement <span class="checkbox unchecked">☐</span> Biosynthetic/fermentation product <span class="checkbox checked">✓</span> Works through natural pathways/receptors <span class="checkbox checked">✓</span> Facilitates natural physiological processes <span class="checkbox unchecked">☐</span> No identified natural connection

<h2>1. NATURAL DERIVATION ASSESSMENT</h2>

<p>### <h3>Source Investigation</h3> BROMOCRIPTINE is produced through modification of natural compounds, preserving the essential natural framework while enhancing therapeutic properties. Bromocriptine is a semi-synthetic derivative of ergot alkaloids, specifically derived from ergotamine, which occurs naturally in the fungus Claviceps purpurea (ergot fungus). This fungus grows parasitically on rye and other cereal grains. The ergot alkaloids have been recognized since medieval times, though their therapeutic properties were first systematically studied in obstetrics and migraine treatment. The compound was developed through pharmaceutical research. derivation as a semi-synthetic ergot alkaloid with clear structural relationships to naturally occurring compounds. The medication integrates directly with endogenous dopamine receptor systems and facilitates natural physiological processes including hormonal regulation and neurological function. Evidence supports both direct natural heritage through ergot alkaloid derivation and functional integration with evolutionary conserved neurotransmitter pathways. <p><strong><strong>Relevant Citations:</strong></strong></p></p>

<ol>

<li>DrugBank Online. &quot;Bromocriptine&quot; DrugBank Accession Number DB01200. University of Alberta. Available at: https://go.drugbank.com/drugs/DB01200 2. PubChem. &quot;Bromocriptine&quot; PubChem CID 31101. National Center for Biotechnology Information, National Library of Medicine.</li>

<li>Flückiger E, Wagner HR. &quot;2-Br-α-ergokryptin: Beeinflussung von Fertilität und Laktation bei der Ratte.&quot; Experientia. 1968;24(10):1130-1131.</li>

<li>FDA. &quot;Parlodel (bromocriptine mesylate) Prescribing Information.&quot; Initial approval 1978, revised 2020. Validus Pharmaceuticals.</li>

<li>Schiff PL Jr. &quot;Ergot and its alkaloids.&quot; American Journal of Pharmaceutical Education. 2006;70(5):98.</li>

<li>Kvernmo T, Härtter S, Burger E. &quot;A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.&quot; Clinical Therapeutics. 2006;28(8):1065-1078.</li>

<li>Molitch ME. &quot;Diagnosis and Treatment of Pituitary Adenomas: A Review.&quot; Journal of the American Medical Association. 2017;317(5):516-524.</li>

<li>Beaulieu JM, Gainetdinov RR. &quot;The physiology, signaling, and pharmacology of dopamine receptors.&quot; Pharmacological Reviews. 2011;63(1):182-217.</li>

<li>Webster J. &quot;A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.&quot; Drug Safety. 1996;14(4):228-238.</li>

</ol>
        </main>

        <footer class="footer">
            <p>Generated on September 24, 2025 at 07:19 AM</p>
        </footer>
    </div>
</body>
</html>